Return to CG100 Overview

Alcohol-use disorders: diagnosis and clinical management of alcohol-related physical complications [CG100]

Measuring the use of this guidance

Recommendation: 1.1.2.2

Follow locally specified protocols to assess and monitor patients in acute alcohol withdrawal. Consider using a tool (such as the Clinical Institute Withdrawal Assessment – Alcohol, revised [CIWA–Ar) as an adjunct to clinical judgement

What was measured: Whether a specific withdrawal assessment tool was used for those at risk of withdrawal
Data collection end: June 2011
9.9%
Number that met the criteria: 32 / 322
Area covered: National
Source: NCEPOD - Measuring The Units


Recommendation: 1.1.3.1

Offer pharmacotherapy to treat the symptoms of acute alcohol withdrawal as follows: • Consider offering a benzodiazepine or carbamazepine • Clomethiazole may be offered as an alternative to a benzodiazepine or carbamazepine. However, it should be used with caution, in inpatient settings only and according to the summary of product characteristics.

What was measured: Whether withdrawal treatment was given when it should have been given
Data collection end: June 2011
81.9%
Number that met the criteria: 118 / 145
Area covered: National
Source: NCEPOD - Measuring The Units


Recommendation: 1.2.1.1

Offer thiamine to people at high risk of developing, or with suspected, Wernicke's encephalopathy. Thiamine should be given in doses toward the upper end of the 'British national formulary' range. It should be given orally or parenterally as described in recommendations 1.2.1.2 to 1.2.1.4.

What was measured: Patients who were current drinkers who had thiamine offered
Data collection end: June 2011
89%
Number that met the criteria: 355 / 394
Area covered: National
Source: NCEPOD - Measuring The Units


Recommendation: 1.3.1.1

Exclude alternative causes of liver disease in people with a history of harmful or hazardous drinking who have abnormal liver blood test results.

What was measured: Judged by assessors as having had an adequate liver screen where this was their first presentation of liver disease
Data collection end: June 2011
46.3%
Number that met the criteria: 57 / 123
Area covered: National
Source: NCEPOD - Measuring The Units

What was measured: Number of patients judged by the assessors to have had an adequate liver screen where this was not their first presentation for liver disease
Data collection end: June 2011
47.2%
Number that met the criteria: 130 / 275
Area covered: National
Source: NCEPOD - Measuring The Units



 Return to CG100 Overview